Pluri Management

Management criteria checks 4/4

Pluri's CEO is Yaky Yanay, appointed in Feb 2014, has a tenure of 10.75 years. total yearly compensation is $741.48K, comprised of 38% salary and 62% bonuses, including company stock and options. directly owns 4.43% of the company’s shares, worth $1.33M. The average tenure of the management team and the board of directors is 2.9 years and 3 years respectively.

Key information

Yaky Yanay

Chief executive officer

US$741.5k

Total compensation

CEO salary percentage38.0%
CEO tenure10.8yrs
CEO ownership4.4%
Management average tenure2.9yrs
Board average tenure3yrs

Recent management updates

Recent updates

Pluri gains as PROTO project receives €7.5M EU grant

Sep 06

Pluristem Therapeutics renames as Pluri

Jul 25

Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?

Dec 04
Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?

We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully

Aug 18
We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully

What Is The Ownership Structure Like For Pluristem Therapeutics Inc. (NASDAQ:PSTI)?

Mar 15
What Is The Ownership Structure Like For Pluristem Therapeutics Inc. (NASDAQ:PSTI)?

We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely

Feb 08
We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely

Pluristem Therapeutics launches $30M registered direct offering

Feb 02

Have Insiders Been Buying Pluristem Therapeutics Inc. (NASDAQ:PSTI) Shares?

Jan 04
Have Insiders Been Buying Pluristem Therapeutics Inc. (NASDAQ:PSTI) Shares?

Pluristem expands COVID-19 program in Mexico

Dec 29

Pluristem - Moment Of Truth

Dec 08

Market Sentiment Around Loss-Making Pluristem Therapeutics Inc. (NASDAQ:PSTI)

Nov 30
Market Sentiment Around Loss-Making Pluristem Therapeutics Inc. (NASDAQ:PSTI)

CEO Compensation Analysis

How has Yaky Yanay's remuneration changed compared to Pluri's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$22m

Jun 30 2024US$741kUS$282k

-US$21m

Mar 31 2024n/an/a

-US$22m

Dec 31 2023n/an/a

-US$24m

Sep 30 2023n/an/a

-US$27m

Jun 30 2023US$3mUS$297k

-US$28m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022n/an/a

-US$33m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022US$1mUS$489k

-US$41m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021n/an/a

-US$51m

Sep 30 2021n/an/a

-US$53m

Jun 30 2021US$9mUS$453k

-US$50m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020n/an/a

-US$37m

Sep 30 2020n/an/a

-US$31m

Jun 30 2020US$350kUS$303k

-US$29m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019n/an/a

-US$31m

Sep 30 2019n/an/a

-US$34m

Jun 30 2019US$887kUS$373k

-US$35m

Mar 31 2019n/an/a

-US$37m

Dec 31 2018n/an/a

-US$28m

Sep 30 2018n/an/a

-US$28m

Jun 30 2018US$443kUS$393k

-US$26m

Compensation vs Market: Yaky's total compensation ($USD741.48K) is about average for companies of similar size in the US market ($USD646.00K).

Compensation vs Earnings: Yaky's compensation has been consistent with company performance over the past year.


CEO

Yaky Yanay (53 yo)

10.8yrs

Tenure

US$741,479

Compensation

Mr. Yaacov Yanay, also known as Yaky, is the Co-Founder of the EyeCue Vision Technologies Ltd. Mr. Yanay has been Chief Executive Officer of Pluri Inc. (formerly Pluristem Therapeutics, Inc.) since June 23...


Leadership Team

NamePositionTenureCompensationOwnership
Yaacov Yanay
President10.8yrsUS$741.48k4.43%
$ 1.3m
Liat Zalts
Chief Financial Officer & Treasurerless than a yearno data0.028%
$ 8.4k
Lior Raviv
Chief Technology Officer2.9yrsno datano data
Arthur Machlenkin
Chief Scientific Officerno datano datano data
Efrat Livne-Hadass
Chief Wellbeing Officerno datano datano data
Orly Amiran
Chief Quality Officerno datano datano data
Efrat Kaduri
Chief Business Development Officer of Pharmano datano datano data
Nimrod Bar Zvi
Chief Commercial Officer2.8yrsno datano data
John Dvor
Executive Vice President of North Americano datano datano data

2.9yrs

Average Tenure

Experienced Management: PLUR's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yaacov Yanay
President9.8yrsUS$741.48k4.43%
$ 1.3m
Doron Birger
Independent Director3.3yrsUS$66.96k0.042%
$ 12.7k
Zami Aberman
Chairman19yrsUS$148.17k2.38%
$ 714.2k
James Roosevelt
Member of Advisory Boardless than a yearno datano data
Yoram Palti
Member of Strategic Advisory Board2.8yrsno datano data
Eilon Tirosh
Member of Strategic Advisory Board2.8yrsno datano data
Richard Kendall
Member of Scientific Advisory Boardless than a yearno datano data
Maital Shemesh-Rasmussen
Independent Director3.4yrsUS$63.55k0.047%
$ 14.2k
Prasad Adusumilli
Member of Scientific Advisory Boardless than a yearno datano data
Rami Levi
Independent Director3.4yrsUS$60.10k0.047%
$ 14.1k

3.0yrs

Average Tenure

70yo

Average Age

Experienced Board: PLUR's board of directors are considered experienced (3 years average tenure).